Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2022 Earnings Call Transcript

Unidentified Analyst: That answers my question. Thank you. My second one is…

Kevin Danahy: Did we lose them? Operator, I think we lost him.

Operator: Yes, that’s correct. The lines dropped. Okay. Ladies and gentlemen, we have reached the end of the question-and-answer session. And I would like to turn the conference over to Kevin Danahy, Chief Executive Officer, for closing comments.

Kevin Danahy: Thank you very much, and thank you, Darrin and Bob for joining me today, and we’re excited about where we are today, and we like the format here where we have the opportunity to answer some of your questions. Hopefully, you felt like the conference call answered a lot of your questions. Just want to let everyone know that as we move forward, we’re going to be head down in our preclinical and product development throughout the closing quarters, and we will update everyone as our new data and the potential of nsPFA comes out, and the significant progress that we’re going to make, and we will continue to report quarterly and communicate updates in a timely and transparent manner that are materials to the business through public communication, calls and press releases. So with that, I would like to thank everyone, and we look forward to talking to you all soon.

Operator: Thank you. The conference of Pulse Biosciences has now concluded. Thank you for your participation. You may now disconnect your lines.